P62(dok), a Negative Regulator of Ras and Mitogen-Activated Protein Kinase (Mapk) Activity, Opposes Leukemogenesis by P210(bcr-abl)

p62(dok) has been identified as a substrate of many oncogenic tyrosine kinases such as the chronic myelogenous leukemia (CML) chimeric p210(bcr-abl) oncoprotein. It is also phosphorylated upon activation of many receptors and cytoplamic tyrosine kinases. However, the biological functions of p62(dok)...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Di Cristofano, Antonio, Niki, Masaru, Zhao, Mingming, Karnell, Fredrick G., Clarkson, Bayard, Pear, Warren S., Van Aelst, Linda, Pandolfi, Pier Paolo
פורמט: Artigo
שפה:Inglês
יצא לאור: The Rockefeller University Press 2001
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2193466/
https://ncbi.nlm.nih.gov/pubmed/11489947
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים